PROCESS OF ARRITMIAS TREATMENT WHICH UNDERSTANDS THE ADMINISTRATION OF AN ADENOSINE A1 AGONIST WITH A BETABLOCKER.

摘要

Use of an adenosine A1 receptor agonist for the preparation of a pharmaceutical composition for the treatment of arrhythmias in a mammal, wherein the pharmaceutical composition is for administering a therapeutically effective minimum dose of the adenosine A 1 receptor agonist together with a Therapeutically effective minimum dose of a beta blocker.